Tiotropium Bromide

Brand name: Spiriva Handihaler

Rank #39 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$478.1M

Total Cost

Share:

673,800

Total Claims

$478.1M

Total Cost

25,545

Prescribers

$710

Cost per Claim

75,865

Beneficiaries

962,918

30-Day Fills

$19K

Avg Cost/Provider

26

Avg Claims/Provider

Share of Medicare Part D Spending

0.17%

of total Medicare Part D spending

$478.1M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $478.1M total

🔎 Data Overview

📊

Ranked #39 out of 500 drugs tracked by total cost. Tiotropium Bromide represents a significant portion of Medicare drug spending.

👤

Average cost of $6,302 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Tiotropium Bromide

#ProviderSpecialtyLocationClaimsCost
1Jorge Sanchez-MasiquesPulmonary DiseaseMiami, FL2,137$1.2M
2Jorge Sanchez-MasiquesPulmonary DiseaseMiami, FL2,215$1.2M
3Andres Bermudez CabaPulmonary DiseaseCoto Laurel, PR937$494K
4Ernesto MejiaPulmonary DiseaseMorristown, TN645$434K
5Rosa Roman CarloPulmonary DiseaseMayaguez, PR827$434K
6Sidharth BaggaInternal MedicineOroville, CA633$389K
7Mohammad-Ali El-HarakehInternal MedicinePrescott, AZ445$381K
8Jon MichelPulmonary DiseasePeoria, IL521$378K
9Luis De Jesus VargasPulmonary DiseaseCaguas, PR660$360K
10Bryson StairNurse PractitionerColumbus, OH604$341K
11Samer AlkhujaPulmonary DiseaseEast Stroudsburg, PA477$322K
12Juan Candelario LanzaPulmonary DiseaseCaguas, PR583$311K
13Luis Nieves GarrasteguiPulmonary DiseaseRio Piedras, PR565$297K
14Clyde SouthwellPulmonary DiseaseHendersonville, TN347$294K
15Eldrige PinedaInternal MedicineWashington, DC510$287K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
36Varicella-Zoster Ge/As01b/Pf (Shingrix)$514.4M2,419,884
37Tafamidis (Vyndamax)$511.1M20,589
38Fluticasone/Vilanterol (Breo Ellipta)$493.0M909,837
39Tiotropium Bromide (Spiriva Handihaler)$478.1M673,800
40Evolocumab (Repatha Sureclick)$460.5M528,560
41Acalabrutinib Maleate (Calquence)$457.0M31,890
42Atorvastatin Calcium (Atorvastatin Calcium)$444.6M30,263,929

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology